Krimo Bouabdallah Selected Research

Krimo Bouabdallah Research Topics

Disease

22	Lymphoma (Lymphomas) 03/2024 - 05/2008
16	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 07/2012
15	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 03/2008
11	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 04/2011
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 01/2007
9	Neoplasms (Cancer) 01/2023 - 01/2007
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2007
4	Residual Neoplasm 03/2024 - 11/2020
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2022 - 01/2020
3	Pneumonia (Pneumonitis) 01/2021 - 03/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 01/2012
3	Disease Progression 01/2017 - 07/2012
2	Infections 12/2023 - 01/2017
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2023 - 01/2013
2	Cytokine Release Syndrome 11/2021 - 01/2021
2	Neutropenia 10/2018 - 01/2017
2	Pathologic Complete Response 01/2018 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 12/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2015 - 01/2011
1	Cytopenia 01/2024
1	Macrophage Activation Syndrome 10/2022
1	Pain (Aches) 02/2022
1	Fatigue 02/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Infertility (Sterility) 01/2019
1	Gastroenteritis 06/2018
1	Mucositis 06/2018
1	Colitis 06/2018

Drug/Important Bio-Agent (IBA)

15	Rituximab (Mabthera)FDA Link 04/2024 - 01/2007
8	obinutuzumabIBA 01/2024 - 08/2013
7	Bendamustine Hydrochloride FDA Link 03/2024 - 01/2013
6	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 01/2020
5	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2020
5	Vinblastine (Vinblastine Sulfate)FDA Link 10/2023 - 01/2018
5	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 04/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 01/2019
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2017
4	NivolumabIBA 01/2022 - 01/2017
4	Monoclonal AntibodiesIBA 01/2021 - 01/2007
3	Chimeric Antigen ReceptorsIBA 01/2024 - 11/2021
3	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 01/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 11/2012
3	copanlisibIBA 01/2021 - 12/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2018
2	Bortezomib (Velcade)FDA Link 04/2024 - 11/2023
2	Brentuximab VedotinIBA 10/2023 - 04/2016
2	pembrolizumabIBA 01/2023 - 01/2020
2	PlatinumIBA 03/2022 - 01/2021
2	ibrutinibIBA 03/2022 - 01/2021
2	axicabtagene ciloleucelIBA 11/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 11/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 11/2020 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2020
2	Carmustine (FIVB)FDA Link 01/2020 - 06/2018
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 04/2011
2	TOR Serine-Threonine KinasesIBA 03/2013 - 07/2012
2	Methotrexate (Mexate)FDA LinkGeneric 11/2012 - 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	AntibodiesIBA 01/2024
1	zanubrutinibIBA 11/2023
1	isatuximabIBA 02/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	cemiplimabIBA 02/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	brexucabtagene autoleucelIBA 01/2023
1	SaltsIBA 03/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2022
1	idelalisibIBA 01/2021
1	Biological FactorsIBA 01/2021
1	tirabrutinibIBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2021
1	venetoclaxIBA 01/2021
1	OligonucleotidesIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	FluorineIBA 01/2020
1	Procarbazine (Matulane)FDA Link 01/2019

Therapy/Procedure

20	Therapeutics 04/2024 - 05/2008
18	Stem Cell Transplantation 12/2023 - 12/2008
14	Drug Therapy (Chemotherapy) 02/2022 - 07/2012
6	Transplantation 11/2020 - 05/2015
5	Cell Transplantation 12/2017 - 01/2017
4	Radiotherapy 11/2018 - 01/2007
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2017 - 12/2017
2	Induction Chemotherapy 11/2020 - 01/2017
2	BEAM regimen 01/2020 - 04/2011
2	Homologous Transplantation 01/2017 - 01/2011
1	Ligation 01/2023
1	Intravenous Infusions 01/2021
1	Immunomodulation 01/2020
1	Immunotherapy 12/2018
1	Splenectomy 12/2018